Glyphic Biotechnologies

We sequence proteins. Glyphic Biotechnologies is a biotechnology startup revolutionizing the field of proteomics. While DNA can reveal biological insights, proteins actually tell us what our bodies will do. We are developing a first-of-its-kind, next-generation protein sequencing platform to enable researchers to gain novel insights into biology and disease.

Research Berkeley, United States ~20 employees Private ยท Venture

Work at Glyphic Biotechnologies in HR or recruiting? Claim this page

Employees
20
+11.1% in the 3 months to Feb 2025
Total funding
$39.2M
Last round Venture, Feb 2024
12-month attrition
37.3%
Tech: 16.7%
H1B filings, FY2026
2
Sponsors visas

Headcount trend

Glyphic Biotechnologies went from 17 employees in Mar 2023 to 20 in Feb 2025. Sep 2024 to Feb 2025: 3 people joined, 1 left.

Headcount data through Feb 2025

Funding rounds

Total funding$39.2M
Funding rounds2
Investors9

Org structure

Headcount by department

Other12
Operations5
Engineering2
Finance1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering2

Peer reviews

Worked with someone at Glyphic Biotechnologies?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Glyphic Biotechnologies FAQ

How many employees does Glyphic Biotechnologies have?

Glyphic Biotechnologies has about 20 employees, up 11.1% over the 3 months to Feb 2025.

Does Glyphic Biotechnologies sponsor H1B visas?

Yes. Glyphic Biotechnologies filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.

How much funding has Glyphic Biotechnologies raised?

Glyphic Biotechnologies has raised $39.2M in total funding.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.